Related Experiment Video

Updated: Sep 4, 2025

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
05:07

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice

Published on: August 25, 2023

1.3K

Pathophysiology, Diagnosis, and Management of Coronary No-Reflow Phenomenon

Gagan Kaur1, Patrick Baghdasaryan1, Balaji Natarajan1

  • 1Department of Cardiology, Riverside School of Medicine, University of California, Riverside, California.

The International Journal of Angiology : Official Publication of the International College of Angiology, Inc
|July 22, 2022
PubMed

Insights

The coronary no-reflow phenomenon, a serious complication after heart artery revascularization, remains poorly understood. Current treatments lack uniform success in preventing adverse outcomes in patients.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Interventional Cardiology

Background:

  • The coronary no-reflow phenomenon is a critical complication following successful revascularization of infarct-related arteries.
  • It is frequently observed after percutaneous coronary interventions and is linked to poor in-hospital and long-term prognoses.
  • While ischemia-reperfusion injury and microembolism are implicated, the precise human pathophysiology is unclear.

Purpose of the Study:

  • To review the current understanding of the pathophysiology of coronary no-reflow.
  • To outline clinical predictors and diagnostic investigations for this condition.
  • To discuss current and proposed management strategies for coronary no-reflow.

Main Methods:

  • Literature review of existing studies on coronary no-reflow phenomenon.
  • Analysis of proposed pathophysiological mechanisms, including ischemia-reperfusion and microembolism.
  • Synthesis of data on clinical predictors, diagnostic tools, and therapeutic interventions.

Main Results:

  • The coronary no-reflow phenomenon is associated with significant myocardial injury and adverse patient outcomes.
  • Despite proposed mechanisms, a comprehensive understanding of its human pathophysiology is lacking.
  • Existing treatment strategies have not consistently demonstrated efficacy in reducing mortality or preventing left ventricular remodeling.

Conclusions:

  • Further research is needed to elucidate the exact mechanisms of coronary no-reflow in humans.
  • Improved diagnostic approaches and targeted therapies are required to mitigate its adverse effects.
  • Effective management strategies are crucial for improving outcomes in patients experiencing this phenomenon.

Keywords:
angiogramcardiac MRIdiagnosismanagementmyocardial blush scoreno-reflow phenomenontreatment

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.1K

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
27
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
24
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
32
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
20
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
42